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Introduction: Chronic obstructive pulmonary disease (COPD) is a common respiratory condition
and the fourth leading cause of death in Canada. However, little is known about the impact of
COPD on the lives and attitudes of individuals living with this condition. The purpose of this
study was to determine whether Canadians with COPD are properly educated and supported,
and to recommend solutions to any care gaps identified.
Methods: A total of 389 Canadians were surveyed who were 40 years of age and older, physi-
cian diagnosed with COPD, and current or former smokers. The telephone survey contained 68
items and took 35 min to complete. COPD severity was classified according to symptom
severity using the Medical Research Council (MRC) score.
Results: Respondents tended to overestimate their disease severity and reported substantial
symptom burden and psychosocial impact of living with COPD. Most individuals claimed to
be well informed about COPD; however, their knowledge was poor in several domains including
the causes of COPD, the consequences of inadequate therapy and the management of exacer-
bations. Family physicians were the main health care providers. A minority of respondents had
seen a lung health educator. Only 34% had ever received a written action plan and only 33% had
been told how to prevent an exacerbation., Halifax Infirmary, 1796 Summer Street, Halifax, NS, B3H 3A7 Canada. Tel.: þ1 902 473 3698;
dha.nshealth.ca (P. Hernandez).
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COPD patient survey of knowledge and attitudes 1005Conclusions: The symptom burden and psychosocial impact of living with COPD is substantial.
There are significant gaps in patients’ knowledge about the management of COPD and little
contact with lung health educators. Increased use of COPD-specific, self-management educa-
tion programs may help rectify these care gaps.
ª 2009 Elsevier Ltd. All rights reserved.Introduction
Chronic obstructive pulmonary disease (COPD) is awell-
characterized chronic lung disease that involves progressive
airflow limitation with symptoms of dyspnea, cough and
sputum production. The most common cause is cigarette
smoking. COPD can impose significant morbidity on indi-
viduals and was the fifth leading cause of death in Cana-
dians in 19991 and the fourth leading cause of death in
2003.2 In Canada, COPD is now more common in women
than in men, with the rate of death from COPD among
women predicted to overtake that of men in the next few
years.2
The 2005 Canadian Community Health Survey deter-
mined that 4.4% of Canadians 35 years of age and older e
nearly 750,000 people e have COPD, based on self-report-
ing of diagnoses made by health care professionals.1 The
annual direct cost of COPD was estimated in the 2003
Confronting COPD Survey to be $1977.81/person.3 Fully
52.5% of this cost is due to hospitalization for COPD exac-
erbations.3 In addition, the indirect annual cost of COPD
was estimated to be $1198.18/person, bringing the total
cost per person per year in Canada to $3195.97. Thus, the
annual economic burden imposed by COPD on society is in
excess of $2.4 billion.
The optimal means of diagnosing COPD and of mini-
mizing its symptoms and exacerbations have been pub-
lished and disseminated in a series of recent consensus
guidelines.4e6 The guidelines have also been formatted
for easier access and use by family physicians, who are
the primary health care providers for COPD in Canada.7
Furthermore, there has been considerable effort by
organizations such as the Canadian Thoracic Society
(CTS) to ensure that the guidelines are widely dissemi-
nated and implemented.8 Less is known about the
impact of guidelines on narrowing the care gap for
patients with COPD; however, one recent physician
study in Ontario and Que´bec has suggested that signifi-
cant COPD care gaps remain.9 It has recently been
demonstrated that one cause of COPD care gaps is poor
patient knowledge or understanding of their symptoms,
warning signs for an exacerbation and actions to be
taken.10
Thus, a survey was undertaken from November 2006 to
February 2007 of a representative sample of Canadians
living with COPD. The primary goal was to identify gaps in
knowledge and attitudes about COPD and its management
among individuals living with COPD. A secondary goal was to
identify unmet educational needs that could assist with the
improvement of educational programs developed by the
Canadian Lung Association (CLA), the CTS, and other key
stakeholder groups.Methods
Study population
A total of 437 Canadians were contacted and invited to
complete the survey. They were all 40 years of age and
older, reported having been diagnosed by a physician with
COPD, chronic bronchitis or emphysema and were current
or former smokers. No objective lung function data was
available. Three-hundred and eighty-nine individuals (89%
response rate) completed the survey. This included 55 who
were identified by random digit dialling across Canada and
334 who were selected from an Ipsos-Reid list of house-
holds containing individuals who reported prior physician
diagnosed COPD, chronic bronchitis or emphysema. Several
questions relating to visits with respirologists and physio-
therapists were addressed only to the individuals who were
identified from the Ipsos-Reid list. The overall distribution
of those surveyed was weighted to match the Canadian
COPD population by age, gender and region using Statistics
Canada data from the Canadian Community Health
Survey.11,12Survey questionnaire
The telephone survey contained 68 items and took
approximately 35 min to complete. The questionnaire was
conceived and written by members of the CTS COPD and
Pulmonary Rehabilitation Committee, the CLA and Ipsos-
Reid. The survey was conducted from November 20, 2006,
to February 11, 2007 by employees of Ipsos-Reid on behalf
of the CTS and CLA. Individuals experienced with pop-
ulation-based surveys conducted the telephone interviews
from a script to minimize bias due to heterogeneity of
multiple interviewers. Although this was the first time the
questionnaire was used in a research study, the question-
naire was piloted to ensure that questions and responses
were unambiguous to respondents.
The first section of the survey ascertained whether
respondents met entry criteria including having been
diagnosed with COPD, chronic bronchitis and/or emphy-
sema, were over 40 years of age and had a history of
smoking. The rest of the interview probed the survey
respondents’ diagnosis and attitudes toward COPD. Many of
the questions focused on the individuals’ knowledge level
and amount of education received from health care
professionals. The information solicited included: the
respondents’ understanding of the disease’s impact on their
daily lives; their current pharmacotherapy and its
perceived effectiveness; the health care providers they had
seen in the last year and what routine management or
1006 P. Hernandez et al.emergency care actions were undertaken in concert with
them; whether the individuals had learned anything more
about COPD since their diagnosis and if so from whom; and
demographic details such as presence of co-morbidities,
amount and frequency of smoking, education level, and
employment and income status.
Subjects were classified according to symptom severity
using the Medical Research Council (MRC) score based upon
their response to questions about breathlessness.6 An MRC
score of 1 was classified as ‘‘asymptomatic’’, MRC 2 as
‘‘mild’’, MRC 3 or 4 as ‘‘moderate’’, and MRC 5 as
‘‘severe’’. The following questions and responses were
used in the interviews. Question: Which of the following
best describes how breathless you get? Possible responses:
Too breathless to leave home; breathless walking a few
minutes, even when walking at my own pace; walk slower
than people my own age; breathless hurrying on level
ground; breathless only after strenuous exercise. Ques-
tion: Do you feel breathless when? Possible responses:
Sitting or lying still; talking; getting washed or dressed;
doing light housework; walking up a flight of stairs; none
of these.
For the purpose of this survey a precise definition of
a COPD exacerbation was not provided to respondents;
rather, respondents were asked questions about ‘‘flare-
ups’’ of their lung disease; specifically, an exacerbation
was counted if subjects reported a flare-up of their lung
disease associated with an increase in symptoms of short-
ness of breath, cough and/or phlegm lasting for two or
more days. Respondents were asked about the frequency in
the past year and consequences of flare-ups and whether
they had been given any advice, including written action
plans, for dealing with these flare-ups.0
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Figure 1 Subject perception of disease severity compared
with symptom severity as determined by the Medical Research
Council (MRC) dyspnea scale. For purposes of this comparison,
MRC grade 1 (asymptomatic) and 2 are combined as mild, MRC
3 and 4 are moderate, and MRC 5 is severe.Survey accuracy and statistical analyses
With a sample of 389 individuals with COPD, the results
were considered accurate to within 4.9 percentage
points, 19 times out of 20, compared to the results of
a putative survey of the entire Canadian COPD population.
The margin of error was larger for specific subgroups within
the survey population e for example, the results from
a 100-person subgroup would have a margin of error of 9.8
percentage points, while those from a 50-person subgroup
would have a margin of error of 13.9 percentage points,
19 times out of 20.
Chi-square test was used to test the hypothesis of
association between dyspnea severity with respondents’
attitudes towards COPD medications and psychological
impact of living with COPD. Unadjusted logistic regression
was used to analyze the association between medication
use and symptom frequency across the Medical Research
Council (MRC) dyspnea scale groups.13 Medication use (long-
acting anticholinergic, LABA/ICS combination, LABA alone,
ICS alone and SABA) and symptom frequency during an
exacerbation (i.e. increased shortness of breath, increased
phlegm or sputum production and increased cough) were
each modelled separately as the outcomes. A p value of
<0.05 was considered statistically significant. Statistical
analyses were performed using SAS software, version 9.1
(SAS Institute Inc., Cary, NC).Results
Respondents’ demographics
Among the individuals that completed the survey, 30% were
from western Canada, 30% from Ontario, 20% from Quebec,
and 20% from the Atlantic Provinces. Fifty-two percent of
respondents were male and 52% were 65 years of age or
older. Forty-one percent reported some post-secondary
education as highest education level obtained. At the time
of the survey, only 19% were employed outside the home.
Fifty-one percent were diagnosed with COPD greater than
5 years before the survey was conducted. Twenty-nine
percent were current and 71% former smokers.
COPD severity and symptom impact
All respondents received a prior diagnosis from a physician
of COPD (78%), chronic bronchitis (55%) and/or emphysema
(41%), with some reporting more than one of the three
diagnoses. Subjects reported their perception of their
disease severity by responding to the question: Overall,
how severe is your condition now? Is it mild, moderate, or
severe? Disease severity reported by the respondents was
higher when compared to their self-assessment with
symptom severity as determined using the MRC dyspnea
scale. (Fig. 1). For the purposes of analysis in Fig. 1, MRC 1
(26%) and 2 (30%) were combined and called mild (56%).
Patient perception of their disease being completely or
well-controlled decreased with symptom severity, dropping
from 50% among those mildly symptomatic, 49% moderately
symptomatic, and 25% of those severely symptomatic.
Shortness of breath or painful breathing, and limitation
of physical activity by symptoms were cited by 55 and 43%
of respondents, respectively, as being the ‘‘most troubling’’
87%
42%
28%
21%
19%
10%
8%
6%
3%
General practitioner/ family doctor
Respirologist or Lung Specialist*
Respiratory therapist
Lung Heath Educator
Nurse
Dietician
Physiotherapist*
Occupational therapist
Psychologist
Figure 2 Respondents’ contact with various health care
professionals over the year preceding the survey. *334 of 389
questioned about contact with these health care professional
groups.
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symptoms to occur ‘‘every day’’ or ‘‘most days’’ included
coughing (56%), shortness of breath (55%), bringing up of
phlegm or sputum (46%), and being awakened by their
symptoms on all or most nights (11%).
Respondents with severe dyspnea were significantly
more likely than respondents with less severe dyspnea to
report a negative psychological impact of COPD on their
lives. (Table 1)
In terms of the impact of COPD on daily activities, 60 and
89% of those with moderate and severe dyspnea, respec-
tively, said that their COPD limited their sports and recre-
ation ‘‘a lot,’’ compared with 29 and 37% of those who were
asymptomatic or had mild dyspnea, respectively. A similar
response pattern by symptom severity was also seen for the
impact of COPD on normal physical exertion, housekeeping
chores, social activities, family activities, sex life and
sleeping. With respect to COPD impact on work, 31% of
respondents were retired or unemployed at the time of the
survey; of the remainder, 30% reported that COPD kept
them from working, highest amongst those with severe
dyspnea (68%). Furthermore, 40% of those who were
currently working said the disease limited the types or
amount of work they could do, and 14% said they had lost
days of work in the previous year because of COPD.
No significant differences appeared in a sub-analysis of
the patients’ responses about the severity of their dyspnea
by region of residence. Individuals in Quebec tended to
view their condition as being slightly more severe than their
counterparts across the country, but they also tended to
report feeling more in control of their condition and having
more confidence in their treating physicians.
Medical management of COPD
The survey confirmed that the vast majority of health care
visits for COPD were with general practitioners (Fig. 2).
Respondents with more severe dyspnea were more likely to
visit health care professionals. There was an average of 5.7
visits per year to a general practitioner or family physician
per respondent. With respect to other health resource
utilization related to COPD in the previous 12 months, 21%Table 1 Psychological impact of living with COPD related to dy
‘‘Agree strongly/somewhat’’ Dyspnea se
Asymptom
(nZ 105)
I often feel sad about having my condition 44
I panic or get afraid when I can’t get my breath 44
If you have it, you are always suffering 36
I often feel guilty about having my condition 33
I often worry about having a flare-up when I am
away from home
23
My cough or breathing is embarrassing in public 17
I have a hard time making plans because I never
know how I will be feeling
17
n, number of respondents. The chi square test was used to investigate
levels of dyspnea severity combined) and responding agree strongly/so
indicated by )p < 0.0001 or #p < 0.05.reported having any hospitalizations; 25% had been to an
emergency department; and 21% had an unscheduled visit
to a clinic. A minority of respondents had more than one of
each type of visit.
Most respondents reported having confidence in their
doctors’ knowledge of COPD. For example, 88% agreed or
strongly agreed with the statement, ‘‘My doctor is very
knowledgeable about my condition and treatment,’’ while
71% agreed or strongly agreed that, ‘‘My doctor teaches me
how to manage the ongoing symptoms of my condition.’’
Far fewer reported negative comments about their physi-
cians. For example, 30% agreed or strongly agreed with the
statement, ‘‘My doctor thinks my condition is my fault,’’
and 20% agreed or strongly agreed that, ‘‘My doctor does
not understand what it is like to suffer from my condition.’’
Spirometry was reportedly done in a large proportion of
respondents; 80% reported having spirometry as part of
their diagnostic work-up, and 67% reported having at leastspnea severity.
verity
atic
(%)
Mild
(nZ 121) (%)
Moderate
(nZ 118) (%)
Severe
(nZ 45) (%)
48 61 88)
51 51 67)
42 59 85#
42 41 68)
39 43 69)
43 40 70)
30 49 75)
an association between dyspnea severity (severe versus all other
mewhat for each question. Statistically significant differences are
64% 63%
58%
16%
90%
51% 54%
60%
0%
20%
40%
60%
80%
100%
Healthy
eating
Regular
exercise
Smoking
cessation
Pulmonary
rehabilitation
Recommended
Followed
Figure 3 Advice regarding non-pharmacological interven-
tions given versus advice followed by respondents for COPD
management.
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percent of respondents with severe dyspnea had spirometry
testing several times in the past year, compared with 19% of
those with moderate dyspnea, 11% of those with mild
dyspnea and 9% of those asymptomatic. Sixty-five percent
of respondents reported having a chest radiograph in the
previous year; those with severe dyspnea reporting the
highest rate, at 77%. Other commonly performed tests
reported in the previous year included electrocardiograms
(50%), pulse oximetry (50%), arterial blood gases (31%) and
computed tomography or magnetic resonance imaging
scans (26%).
The survey also probed the frequency of pharmacolog-
ical and non-pharmacological treatment interventions
(Fig. 3). The most common non-pharmacological interven-
tion was advice about healthy eating, followed by advice
about exercise and smoking cessation. Pulmonary rehabili-
tation was only recommended to 16% of respondents, but
60% of those individuals actually attended a program.
The most popularly prescribed class of medications was
short-acting beta agonists with 69% of respondents reporting
their use. This was followed by anticholinergics (61%), the
combination of long-acting beta agonists and inhaled corti-
costeroids (44%), and inhaled corticosteroids alone (19%).*
0%
20%
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60%
80%
Long-acting
anticholinergic
LABA/ICS
combination
LABA
A
M
M
S
Figure 4 Relationship between reported inhaled drug therapy us
Council (MRC) dyspnea scale. ) indicates significant difference inThe distribution of inhaledmedication by dyspnea severity is
shown in Fig. 4. There were statistically significant differ-
ences related to dyspnea severity in pattern of use of short-
acting beta-agonists and long-acting anticholinergics, but
not for other inhaled medications. Fully 83% of patients said
they did not use non-prescription medications, while 6% said
they used over-the-counter cough and/or cold syrups.
With respect to attitudes towards COPD medications,
inhalers were reported as effective by 89% of respondents,
and 68% said they always carry their inhaler with them
(Table 2). There were concerns expressed about medica-
tions, which are potential barriers to patient adherence
with taking them as prescribed, particularly among
respondents with severe dyspnea. Seventeen percent said
they had been prescribed home oxygen, while 30% were not
currently using it. Improvement in symptoms was the most
commonly offered reason for stopping home oxygen.
Coping with COPD flare-ups
Flare-ups or exacerbations are the most common reason for
contact between COPD sufferers and the health care system,
and 81% of respondents reported experiencing at least one
flare-up in the previous 12 months. In general, frequency of
increased symptoms (shortness of breath, cough and/or
phlegm) associated with flare-ups were significantly related
to MRC dyspnea severity (Fig. 5). Respondents had varied
perceptions regarding the nature and causes of exacerba-
tions. For example, 44% reported that their own actions/
physiological factors could cause exacerbations of COPD,
while 34% felt environmental factors were to blame. Other
possible causes of flare-ups provided by respondents
included strenuous activity (26%), psychological factors
(21%), stress (17%), allergies (17%), smoking (15%), colds
(13%), ‘‘flus’’ (5%) and chest infections (4%). Sixteen percent
said they did not know what caused flare-ups.
Respondents’ perceptions of the most effective ways to
prevent flare-ups were similarly varied and reflected to
some extent the perceived causes. For example, 21% said
they believed an effective preventive action is to take their
prescribed medication, 20% cited smoking cessation, 15%*
 alone ICS alone SABA
symtomptomatic (MRC 1)
ild (MRC 2)
oderate (MRC 3 & 4)
evere (MRC 5)
e and symptom severity as determined by the Medical Research
medication use related to symptom severity (p < 0.05).
Table 2 Respondents’ attitudes towards COPD medications related to dyspnea severity.
‘‘Agree strongly/somewhat’’ Dyspnea severity
Asymptomatic
(nZ 105) (%)
Mild
(nZ 121) (%)
Moderate
(nZ 118) (%)
Severe
(nZ 45) (%)
Inhalers are effective in providing
relief from symptoms
92 92 83 88
I always carry an inhaler with me 57 73 68 81
My current medication schedule makes
it difficult to lead an active life
9 21 22 39#
I get embarrassed using my
medication in public
10 17 20 32)
My medication does not help
me very much
12 18 20 41)
I have unpleasant side effects
from my medication
14 11 20 30#
n, number of respondents. The chi square test was used to investigate an association between dyspnea severity (severe versus all other
levels of dyspnea severity combined) and responding agree strongly/somewhat for each question. Statistically significant differences are
indicated by )p < 0.0005 or #p < 0.05.
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that avoiding stress was effective. Only 4% reported being
careful to avoid infection as a useful prevention strategy.
Seventeen percent said they do not know how to prevent
flare-ups.
Eighty-three percent of those surveyed said they knew
how to cope with flare-ups. However, 64% agreed or
strongly agreed with the statement, ‘‘I wish I had more
information on how to deal with my flare-up.’’ Moreover,
many felt they knew how to prevent flare-ups and could
easily control them, 35% agreed or strongly agreed with the
statements, ‘‘I constantly worry about getting a flare-up’’
and ‘‘My doctor hasn’t been able to help me reduce [the]
severity of my flare-ups.’’ Those with severe COPD reported
being significantly more likely to worry about flare-ups and
their deleterious consequences than did those with milder
disease.49% 52%
65% 67%
73%
77%
0%
20%
40%
60%
80%
100%
Increased shortness of
breath
Increased ph
prod
*
Figure 5 Increasing frequency of symptoms during flare-ups re
Council (MRC) dyspnea scale. ) indicates significant difference inPerceived consequences of a flare-up included 79% of
respondents who reported that flare-ups can affect their
survival, 71% cited the need for a rescue medication, an
unscheduled physician visit (62%), an emergency depart-
ment visit (57%), admission to hospital (56%), death (46%),
and the need for intubation (25%). Eighty percent of
respondents reported taking medication when they had
a flare-up. Forty-one percent visited their doctor, 26%
spoke to their physician on the phone and 19% visited an
emergency department. Forty-eight percent of respondents
delayed contacting a physician for longer than 1 day after
the onset of the flare-up. Thirty-two percent reported that
the duration for ‘‘time to recovery’’ from the flare-up was
greater than a week.
Despite the awareness among respondents of the serious
consequences of flare-ups, they reported having received
little education from their physicians about how to self-53%
68%65%
72%
76% 76%
legm or sputum
uction
Increased cough
Asymtomptomatic (MRC 1)
Mild (MRC 2)
Moderate (MRC 3 & 4)
Severe (MRC 5)
*
*
lated to symptom severity according to the Medical Research
symptom frequency related to symptom severity (p < 0.05).
78%
55%
34%
34%
34%
33%
32%
Written you a prescription for an
inhaler to use when you experience
a flare-up
Provided you with a written action
plan or set of instructions of what to
do when you get a flare-up
Given you a free sample of
medication to use when you
experience a flare-up
Described the warning signs of a
flare-up
Told you what to do if you
experience a flare-up
Written you a prescription for pills to
use when you experience a flare-up
Told you how to prevent a flare-up
Figure 6 Respondents’ reports of education provided by
physicians regarding self-management of exacerbations.
1010 P. Hernandez et al.manage these acute events (Fig. 6) and only a third had
a written action plan to follow during a flare-up.
COPD education and public awareness
Only half of respondents felt that COPD was accurately
depicted by the media and 37% believed that the public was
well educated about the disease. Sixty-three percent
agreed that educating the public would decrease the
stigma associated with living with COPD.
The vast majority of respondents had a positive picture
of their knowledge about COPD. Eighty-nine percent
strongly agreed or agreed with the statement, ‘‘I feel I am
very well informed about how to manage my condition.’’
Yet, 39% strongly agreed or agreed with the statement,
‘‘People with this condition are powerless to control its
progression’’, while 47% strongly agreed or agreed with the
statement, ‘‘I feel I am not in control of my breathing
problem.’’ Those with severe disease were significantly
more likely than others to strongly agree or agree with
these statements.
Overall, respondents were more informed about their
COPD at the time of survey than they had been at the time
of their diagnosis. Sixty percent indicated that their COPD
education came from health care professionals, but only 5%
cited a lung health educator as the source. Forty-nine
percent cited reading materials and information in the
media including the Internet as important COPD-education
sources, while 23% cited health organizations such as
clinics, hospitals and rehabilitation centres as information
sources they used. Another 6% said they relied on their own
experience and 4% relied on their peers, family, friends and
acquaintances. Those with severe dyspnea reported higher
rates of information-gathering from clinics, hospitals and
rehabilitation centres, and from their own experience.
Discussion
This study is the largest survey ever undertaken in Canada
of COPD patients’ perceptions and education regardingtheir disease, its severity and treatment, and their rela-
tionship with health care professionals. As such, this survey
complements the recent study of primary care physician
COPD management practices in Ontario and Que´bec.9
This study revealed that the symptom burden and
psychosocial impact of living with COPD was substantial,
particularly for those with more severe dyspnea. The
results also indicated that most individuals with COPD felt
well informed about their condition. However, their
knowledge was poor about the causes of COPD, the
consequences of inadequate therapy and the management
of exacerbations. The survey results also confirmed that the
vast majority of COPD patients’ contact with the health
care system for this disease occurs in the form of visits with
their general practitioners or family physicians.
There were a number of potential shortcomings of this
study design. The methodology relied on subject self-report
and recall during a telephone interview. There was no
confirmation of the physician diagnosis of COPD with
objective lung function testing, nor attempts to review
physician or hospital records. There may also have been
a self-selection bias among respondents in spite of efforts
to select a population representative of the Canadian
population living with COPD. COPD is a complex disease;
severity is best characterized using multiple assessment
tools (e.g. symptom scores, lung function, exercise
capacity, nutritional status, etc.). However, in this study,
MRC dyspnea score was used as a surrogate for disease
severity as it has been shown to correlate with important
clinical outcomes such as quality of life and survival and
was the most practical means to assess disease severity in
this population-based survey.14,15
It was a surprise that the majority of respondents
reported having had spirometry at the time of diagnosis.
This conflicts with the general perception that pulmonary
function tests are underutilized in Canada, particularly in
primary care, to confirm the diagnosis of COPD.16 In the
recent CAGE study, only 56% of primary care physicians
reported that their COPD patients had ever undergone
spirometry testing.9 This discrepancy may be accounted for
by a selection bias of respondents coming largely from
a pre-existing list of households containing a COPD patient.
In keeping with our current understanding of COPD,
symptoms were most troublesome to patients with severe
dyspnea as determined by MRC dyspnea scale. We also
observed that the cardinal COPD symptoms of shortness of
breath, cough and phlegm had important negative impacts
on all activities of daily living, quality of life and psycho-
logical well-being of respondents, especially for those living
with severe dyspnea.
The majority of respondents reported regular use of
a number of medications for treatment of COPD, but the
pattern of medication use was discordant with current CTS
guidelines for COPD management.7 For example, long-
acting anticholinergics, inhaled corticosteroids and combi-
nation long-acting beta-2-agonist/inhaled corticosteroid
medications were over prescribed for patients reporting
only mild dyspnea. Similar observations were reported in
the CAGE study.9
Non-pharmacological therapies, such as pulmonary
rehabilitation and self-management education, have been
shown to reduce symptom burden, improve health-related
COPD patient survey of knowledge and attitudes 1011quality of life, and reduce health resource utilization in
COPD.17e21 Non-pharmacological therapies were underu-
tilized in the survey population with only 16% referred to
pulmonary rehabilitation and only 5% who reported seeing
a lung health educator. The reasons for this care gap,
whether due to poor physician and patient awareness or
lack of availability, were not explored in this study;
however, it is known that existing pulmonary rehabilitation
programs have a capacity to serve only about 1% of the
estimated COPD population in Canada.22
There are major health care costs associated with
providing care for COPD in Canada23; respondents reported
frequent scheduled and unscheduled visits to physicians,
emergency department visits and admissions to hospital,
particularly during exacerbations. Exacerbations are costly
to patients and the health care system, are the most
common reason for medical visit, contribute to acceler-
ated decline in lung function and quality of life, and
increased mortality in COPD.6 The majority of respondents
reported at least one exacerbation in the year prior to the
survey. Although at least half of COPD exacerbations are
thought to have an infectious etiology,6 few respondents
recognized this fact or understood the role of avoiding
infection as a preventative strategy. Written action plans
were used by only a third of respondents to manage
exacerbations. Clearly, better patient education regarding
the prevention and management of exacerbations is
required.
Most respondents relied on their physicians for educa-
tion about COPD. There was, however, a disturbing
discordance between respondents’ perception and the
reality of their level of knowledge of COPD. One possible
solution is collaborative, self-management education
involving patient, family caregivers, primary care physi-
cians, specialists and COPD educators/case managers. At its
core, self-management education involves formalized
education programs aimed at helping the patient and
family improve their knowledge and skills relating to COPD,
increasing their self-confidence, and helping them to act
decisively and correctly at all stages of the disease,
including during exacerbations.24,25 Self-management
education has been shown to significantly reduce the rate
of emergency-room visits and hospitalization due to acute
COPD exacerbations.17e21 However it is clear that to
support widespread self-management education programs
in Canada, the existing healthcare delivery system and
health professionals’ education will have to be
modified.24,25
In the 2005 COPD Report Card produced by the Canadian
Lung Association, it was noted that public awareness and
media coverage of COPD is low compared to many other
chronic diseases in Canada.16 Respondents of the current
survey made similar comments and noted the negative
stigma attached to COPD. Individuals living with COPD are
often elderly, frail and socially isolated and need help to
effectively advocate for more social supports and health
care services. Patient advocacy groups, such as the CLA,
need to do more to raise the profile of COPD among the
general public, health care administrators and health policy
decision makers. Hopefully, more effective advocacy will
result in improved access to health care services, such as
pulmonary rehabilitation programs and self-managementeducation by lung health educators. Improved utilization of
effective interventions will help relieve the substantial
psychological and physical symptom burden and narrow the
knowledge gap seen in this survey of individuals living with
COPD.
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